Cardiovascular mortality remains high among peritoneal dialysis (PD) patients. Several small studies have suggested that PD patients are volume expanded, and as such this could be a cardiovascular risk factor. We therefore wished to investigate factors which could lead to extracellular water (ECW) expansion.
Methods:
Retrospective cross-sectional audit of 600 prevalent, adult PD patients attending two tertiary university PD centers, with corresponding assessments of PD adequacy, transport status, and multifrequency bioimpedance measurements of extracellular water to total body water (ECW/TBW).
Results:
600 PD patients, median age 57.5 (46.9–67.9) years, 54% male, 31% diabetic, 47.6% Caucasoid, median PD vintage 16 (3.7–38) months, (64% prescribed icodextrin, 34% hypertonic glucose dialysates, and 74% antihypertensive medications). Mean ECW 15.1±0.2 L, ICW 20±0.2 L, ECW/TBW ratio 0.437±0.007. On multivariate analysis %ECW/TBW was associated with age (F=13.1 β=0.045 p=0.000), number of antihypertensive medications (F=10.3 β=0.43 p=0.001), log CRP (F=12.9 β=1.3 p=0.000), and negatively with serum albumin (F=25 β=-0.22 p=0.000), and residual renal function (urine volume mL F=9.96 β=-0.001 p=0.002) (weekly Kt/Vurine F=8.82 β=-2.05, p=0.003).
Conclusions:
Overhydration as assessed by ECW/TBW is prevalent in adult PD patients, and is associated with loss of residual renal function, inflammation, malnutrition and hypertension – as assessed by antihypertensive medications. As this was a retrospective cross-sectional audit, whether loss of residual renal function, inflammation, and protein energy wasting lead to volume expansion remains to be determined in prospective longitudinal studies.
DavenportA., CoxC., ThuraisinghamR.. Achieving blood pressure targets during dialysis improves control but increases intradialytic hypotension.Kidney Int.2008; 73(6): 759–764. Medline. doi: 10.1038/sj.ki.5002745
3.
JagerK.J., MerkusM.P., DekkerF.W.Mortality and technique failure in patients starting chronic PD: results of The Netherlands Cooperative Study on the Adequacy of Dialysis. NECOSAD Study Group.Kidney Int.1999; 55(4): 1476–1485. Medline. doi: 10.1046/j.1523-1755.1999.00353.x
4.
WangA.Y., LamC.W., YuC.M.N-terminal probrain natriuretic peptide: an independent risk predictor of cardiovascular congestion, mortality, and adverse cardiovascular outcomes in chronic PD patients.J Am Soc Nephrol.2007; 18(1): 321–330. Medline. doi: 10.1681/ASN.2005121299
5.
BoothJ., PinneyJ., DavenportA.. N-terminal proBNP–marker of cardiac dysfunction, fluid overload, or malnutrition in hemodialysis patients?Clin J Am Soc Nephrol.2010; 5(6): 1036–1040. Medline. doi: 10.2215/CJN.09001209
6.
PapakrivopoulouE., LillywhiteS., DavenportA.. Is N-terminal probrain-type natriuretic peptide a clinically useful biomarker of volume overload in PD patients?Nephrol Dial Transplant.2012 Jan; 27(1): 396–401.
7.
MichelsW.M., VerduijnM., BoeschotenE.W., DekkerF.W., KredietRT; NECOSAD Study Group. Similar survival on automated PD and continuous ambulatory PD in a large prospective cohort.Clin J Am Soc Nephrol.2009; 4(5): 943–949. Medline. doi: 10.2215/CJN.04440908
8.
ChenW., GuoL.J., WangT.. ECW /intracellular water is a strong predictor of patient survival in incident PD patients.Blood Purif.2007; 25(3): 260–266. Medline. doi: 10.1159/000101699
9.
DavenportA.. Peritonitis remains the major clinical complication of PD: the London, UK, peritonitis audit 2002–2003.Perit Dial Int.2009; 29(3): 297–302.
10.
BalasubramaniamG., BrownE.A., DavenportA.The Pan-Thames EPS study: treatment and outcomes of encapsulating peritoneal sclerosis.Nephrol Dial Transplant.2009; 24(10): 3209–3215. Medline. doi: 10.1093/ndt/gfp008
11.
HabibA.M., PrestonE., DavenportA.. Risk factors for developing encapsulating peritoneal sclerosis in the icodextrin era of PD prescription.Nephrol Dial Transplant.2010; 25(5): 1633–1638. Medline. doi: 10.1093/ndt/gfp677
12.
DavenportA., WillicombeM.. Comparison of fluid status in patients treated by different modalities of PD using multi-frequency bioimpedance.Int J Artif Organs.2009; 32(11): 779–786.
13.
DavenportA., WillicombeM.K.. Hydration status does not influence peritoneal equilibration test ultrafiltration volumes.Clin J Am Soc Nephrol.2009; 4(7): 1207–1212. Medline. doi: 10.2215/CJN.01060209
14.
KeshaviahP.R., NolphK.D., ProwantB.Defining adequacy of CAPD with urea kinetics.Adv Perit Dial.1990; 6: 173–177.
15.
TwardowskiZ.J.. PET–a simpler approach for determining prescriptions for adequate dialysis therapy.Adv Perit Dial.1990; 6: 186–191.
16.
KoningsC.J., KoomanJ.P., SchonckM.Assessment of fluid status in PD patients.Perit Dial Int.2002; 22(6): 683–692.
17.
WoodrowG.. ECW expansion: part of the malnutrition-inflammation-atherosclerosis syndrome?Perit Dial Int.2006; 26(5): 566–570.
18.
WoodrowG., DevineY., CullenM., LindleyE.. Application of bioelectrical impedance to clinical assessment of body composition in PD.Perit Dial Int.2007; 27(5): 496–502.
19.
BargmanJ.M., ThorpeK.E., ChurchillD.N.; CANUSA PD Study Group. Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA study.J Am Soc Nephrol.2001; 12(10): 2158–2162.
20.
TermorshuizenF., KorevaarJ.C., DekkerF.W., van ManenJ.G., BoeschotenE.W., KredietR.T.; NECOSAD Study Group. The relative importance of residual renal function compared with peritoneal clearance for patient survival and quality of life: an analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD) -2.Am J Kidney Dis.2003; 41(6): 1293–1302. Medline. doi: 10.1016/S0272-6386(03)00362-7
21.
KoningsC.J., KoomanJ.P., SchonckM.Fluid status in CAPD patients is related to peritoneal transport and residual renal function: evidence from a longitudinal study.Nephrol Dial Transplant.2003; 18(4): 797–803. Medline. doi: 10.1093/ndt/gfg147
22.
WangT., HeimbürgerO., WaniewskiJ., BergströmJ., LindholmB.. Increased peritoneal permeability is associated with decreased fluid and small-solute removal and higher mortality in CAPD patients.Nephrol Dial Transplant.1998; 13(5): 1242–1249. Medline. doi: 10.1093/ndt/13.5.1242
23.
DaviesS.J., WoodrowG., DonovanK.Icodextrin improves the fluid status of PD patients: results of a double-blind randomized controlled trial.J Am Soc Nephrol.2003; 14(9): 2338–2344. Medline. doi: 10.1097/01.ASN.0000083904.12234.27
24.
DavenportA., WillicombeM.K.. Does diabetes mellitus predispose to increased fluid overload in PD patients?Nephron Clin Pract.2010; 114(1): c60–c66. Medline. doi: 10.1159/000245070
25.
DavenportA.. Interdialytic weight gain in diabetic hemodialysis patients and diabetic control as assessed by glycated hemoglobin.Nephron Clin Pract.2009; 113(1): c33–c37. Medline. doi: 10.1159/000228073
26.
FürstenbergA., DavenportA.. Comparison of multifrequency bioelectrical impedance analysis and dual-energy X-ray absorptiometry assessments in outpatient hemodialysis patients.Am J Kidney Dis.2011; 57(1): 123–129. Medline. doi: 10.1053/j.ajkd.2010.05.022
27.
JonesC.H., WellsL., StovesJ., FarquharF., WoodrowG.. Can a reduction in extracellular fluid volume result in increased serum albumin in PD patients?Am J Kidney Dis.2002; 39(4): 872–875. Medline. doi: 10.1053/ajkd.2002.32010
28.
WoodrowG., OldroydB., WrightA., CowardW.A., TruscottJ.G.. The effect of normalization of ECW volume as a marker of hydration in PD patients and controls.Perit Dial Int.2005; 25(Suppl 3): S49–S51.
29.
Van der KerkhofJ., HermansM., BeerenhoutC., KoningsC., Van der SandeF.M., KoomanJ.P.. Reference values for multifrequency bioimpedance analysis in dialysis patients.Blood Purif.2004; 22(3): 301–306. Medline. doi: 10.1159/000078761
30.
DaviesS.J., Garcia LopezE., WoodrowG.Longitudinal relationships between fluid status, inflammation, urine volume and plasma metabolites of icodextrin.Nephrol Dial Transplant.2008; 23(9): 2982–2988. Medline. doi: 10.1093/ndt/gfn176
31.
JohnB., TanB.K., DaintyS., SpanelP., SmithD., DaviesS.J.. Plasma volume, albumin, and fluid status in PD patients.Clin J Am Soc Nephrol.2010; 5(8): 1463–1470. Medline. doi: 10.2215/CJN.09411209
